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ABSTRACT
Objective: To evaluate anemia as a cause of clinical disability in blood donors in the state of
Maranhão- Brazil. Methods: This study addresses a time series of prevalence of anemia among
blood donor candidates. Secondary data were collected from the Information System of the Blood
Center of Maranhão. Donor candidates were treated between 2001 and 2010. Statistical analysis
was performed with Epi Info version 6.04d. Results: The proportion of clinical disability was
16.8% (n = 1,672) and 63.27% (n = 6,198) consisted of men. Considering the unfit group,
anemia was the second most frequent cause with 16.68% (n = 16,729). In men, drug use was the
most frequent cause of inability (90.94%, n = 650) and anemia was the last cause with 28.76% (n
= 458). In women, anemia was the major cause of clinical inability (71.24%, p = 0.000). Conclu-
sion: Anemia is an important cause of inability, and in women it is the first one.
Key words: Blood Donors. Hemotherapy Service. Anemia.
RESUMO
Objetivo: Avaliar a anemia como causa de inaptidão clínica de candidatos a doação de sangue no
estado do Maranhão. Métodos: Este estudo trata de uma série temporal da prevalência de ane-
mia entre os candidatos doadores de sangue. Foram coletados dados secundários do Sistema de
Informação do Hemocentro do Maranhão. Os candidatos a doação foram atendidos entre os anos de
2001 e 2010. A análise estatística foi realizada com Epi Info versão 6.04d. Os dados foram conside-
rados estatisticamente significativos quando p <0,05. Resultados: A proporção de inaptidão clínica
foi de 16,8% (n=1,672) sendo desses 63,27% (n=6,198) eram homens. Considerando-se o grupo
de inaptos, a anemia foi a segunda causa mais frequente com 16.68% (n= 16,729). Nos homens,
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INTRODUCTION
Blood transfusion becomes vital in several
situations, such as, victims of car accidents, pa-
tients with large burns, hemophilia, anemia, pa-
tients with bleeding problems and other emer-
gencies. Transfusions are performed to increase
the blood’s ability to carry oxygen, restoring blood
volume in the body, improving immunity or to fix
bleeding disorders.1
In Brazil, every blood donation should be
altruistic, voluntary and, direct or indirectly, non-
paid, as well as donor anonymity should be guar-
anteed.2 To be considered able donate, it is nec-
essary thorough clinical trial, and that it had been
submitted to serological screening.3
Some studies found anemia as cause of dis-
ability among clinical candidates for blood dona-
tion in female candidates.3,4,5 Anemia is of the
major public health problems in the world, and
among its symptoms there are tiredness, dizzi-
ness, brittle nails and hair.6
In an agreement made between Brazil and
the United Nations it had decided the decrease
of the prevalence of anemia because of iron defi-
ciency until 2003 in 1/3 of levels of women in re-
productive ages and children7 as well, but the
studies show a diverse direction.8,9 The National
Demographic and Health survey for Children and
Women (PNDS) showed anemia in 29.4% of Bra-
zilian women. In the Northeastern region in Bra-
zil, 40% of the women was in reproductive age.10
Thus, this study aims to evaluate the im-
portance of anemia as a cause of clinical disabil-
ity for blood donation in Maranhão from the years
of 2001 to 2010.
METHODS
This is a time series of the prevalence of
anemia among prospective blood donors from the
Center of Hemotherapy and Hematology
(HEMOMAR - Maranhão), which is the institution
that is responsible for public policy of blood and
blood products in the state of Maranhão.
The project was approved by the Ethics
Committee in Research from the Health Depart-
ment in the State of Maranhão (SES) and the Fed-
eral University of Maranhão (UFMA) (Protocol
n.545548).
The study population was composed of can-
didates for blood donation (CDS) who attended
HEMOMAR in the capital of the state of Maranhão,
São Luís and in the six Hemotherapy Centers lo-
cated in the state, from 2001 to 2010.
Candidates were classified as clinical able
(CA), when after clinical screening they were eligi-
ble to donate blood, or clinical unable (CU), when
considered unable after this screening. These could
be temporary (TCU), when the screening require-
ments were not actually present, but with the
possibility for future donation, or permanent (PCU),
when inability for donation was considered to be
definitive.
The sample was composed only by TCU and
PCU individuals, from 18 to 60 years of both gen-
ders, totalizing 971 candidates for blood donation.
Information was gathered, secondarily, through
Information System Reports from HEMOMAR, dur-
ing the evaluated period.
Determination of hemoglobin concentration
(Hb) or hematocrit (Ht) is some of the criteria laid
down in the selection of candidates for blood do-
nation in order to detect and exclude candidates
by using the determinant “anemia”.11 The minimum
acceptable level values are Hb: 12.5 g / dL or
hematocrit: 38% for women and Hb: 13.0 g / dL or
hematocrit: 39% for men.12
The profile for blood donation was analyzed
by gender, as well as, the prevalence of causes
of clinical disability. In the period from 2001 to
2010, the main reasons for non-donation were,
o uso de drogas foi a causa mais frequente de inaptidão (90.94%; n= 650) e a anemia foi a última
causa com 28.76% (n=458). Em mulheres a anemia representou a maior causa de inaptidão
clínica (71.24%; p=0,000). Conclusão: A anemia configura-se como causa importante de inapti-
dão, principalmente em mulheres, sendo a primeira.
Palavras-chave: Doadores de Sangue. Serviço de Hemoterapia. Anemia.
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anemia, hypertension, hypotension, alcoholism,
Sexually Transmitted Diseases (STD), drug use,
hepatitis, Chagas disease, malaria and others.
These data were organized into spread-
sheets using the software Microsoft Office Excel
version 2007 to measure the frequency of vari-
ables, mean and standard deviation. Statistical
analysis was performed using Epi Info version
6.04d. For the association of frequency distribu-
tion between diseases and the years of evalua-
tion, the Chi-Square Test was used. Data were
considered statistically significant when p <0.05.
RESULTS
From 2001 to 2010, there were recorded in
the blood bank of Maranhão 58,345 blood donors,
and 16.8% (n= 9,797) were considered clinically
unable. Of the total candidates, 63.27% (n=
6,198) were men who had been considered clini-
cally unable, and 36.73% (n= 3,598) of females.
The causes of medical inability to donating
blood, anemia is the third most frequent cause.
The mean average was 16.68% (n= 16,729), af-
ter “Others” (50.72%; n= 50,002) and “risk
behavior for STDs” (20.28%; n= 19,397), repre-
senting the first and second reason, respectively.
The option “Others” refers to candidates who, for
some reason, were not considered able and do
not meet the criteria from the Ministry of Health11,
with high clinical relevance in the selection of can-
didates for blood donation, for example, high tem-
perature, hypotension, cold, underweight, use of
certain drugs, among other process. Thus, if con-
sidering only the cases that have the exact speci-
fication, the option “anemia” becomes the sec-
ond leading cause, with statistical significance
(p = 0.000).
The proportions of causes of clinical disabil-
ity in men, was “Drug Use” (90.94%; n= 650),
“Risky Behavior for STDs” (82.64%; n= 15,965) and
“Alcoholism” (75.73%; n= 169). Anemia is the last
cause of disability (28.76%; n= 4,580) (Table 1).
In women, anemia represents the major
cause of disability (71.24%; n=12,149) (p = 0.000),
followed by “hypotension” (52.36%; n=707) and
“Chagas Disease” (35.17%; n= 16) (Table 1).
The temporal trends according to the total
sample, showed low changes in the rates of
prevalence of anemia among causes of clinical
disability for blood donation, except for in 2004,
when it reached 21.36% (n= 2,401); rate num-
bers dropped in 2007 (14.74%; n=1,275), but
rose in 2008 and reached its peak in 2010
(21.70%; n= 2,781) (Figure 1).
The prevalence of anemia among candi-
dates take divergent characteristics, according to
the individual’s sex. In men, these values de-
creased to reach the lowest percentage in 2008;
in the following year, it increased again and in
2010, it showed a decrease. In women, the trend
in the prevalence of anemia showed increasing
values until 2008; in the following year evidences
fell and rose again in 2010 (Figure 2).
DISCUSSION
The rate of clinical disability of candidates
for blood donation in the state of Maranhão was
16.8%, below the average of the Northeastern
region (20.3%). In 2011, the national average in
2011 was of 16.3%.13
The large number of unable male unable
candidates can be explained by the high demand
for hemotherapy centers; in addition, there is a
minimum range of donations in both sexes; re-
garding men, the interval is shorter than for
women- two and three months respectively.
Another possible cause that has been iden-
tified in this study, refers to sexual behavior. In a
year, people have at least three partners, and with
many sexual relationships, but they do not have
any sexual education on health, prevention, etc.,
making these people more susceptible to STDs.14
A research from the Ministry of Health in
Maranhão (2010), showed rates of blood dona-
tion accounted for approximately one third of the
ideal number of donors.15
The results of this study indicate anemia as
the second leading cause for clinical inability for
blood donation (16.68% ± 2.85). Other studies
showed anemia as a major cause of disability,
among which 17.76%3 and 10.4%5, showed high
prevalence, especially among women candidates
for donation, in the range of 19.3% and 56.15%,
respectively.16 In another study there was a preva-
lence of 80% of women that reported a history of
anemia.17
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Figure 1: Time trends of percentage of anemia as a cause of clinical disability for blood donation, Maranhão, 2001-2010.
Source: HEMOPROD.
Figure 2: Time trends of anemia as a cause of clinical disability for blood donation, according to gender. Maranhão, 2001-2010. Source:
HEMOPROD, 2013.
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Anemia and blood donation.
These results are important when there are
demographic (age) and social (urban violence, car
accidents and others) changes that increase the
demand for blood transfusions4. Therefore, high
rates of clinical and serological disability can re-
sult in deficits in the stocks, with adverse conse-
quences for the population.18
The World Health Organization19 estimates
that two billion people worldwide are anemic and
approximately 90% of the causes is because of
the deficiency of iron. This lack can be triggered
by various factors that determine the negative
iron balance and increased need, great loss, iron
malabsorption of food and iron-deficient diets.20
However, several studies have identified risk fac-
tors for anemia, as socioeconomic determinants,
for example, family income, gender, schooling,
housing, and housing conditions.9
The National Sanitary Surveillance Agency,21
used clinical and hematological screening data
that showed that 18% of all candidates for blood
donation of Brazilian blood centers were excluded,
and 14% of them because of anemia.
This rate was found to be even larger
(41.27%) and anemia was identified as the main
cause of disability among women (56.15%). Our
data confirmed this analysis, since the anemia rep-
resented the first cause of clinical incapacity in fe-
males.16 A study showed that out of 13,200 candi-
dates for blood donation, 58,8% were women and
12,8% of them could not donate blood.6
In the study, 37% of those who searched
for medical care after postponement, 64% of them
had the confirmation of anemia.17 The largest ex-
clusions for donation in women are due to anemia,
due to physiological factors such as the need for
additional iron during reproductive life, especially
during menstruation.22
All blood donors showed different behaviors
in the temporal trends of anemia. This question
showed an upward trend in female candidates
whereas in men, prevalence decreased over the
years. One of the limitations of this descriptive
study is that there is no consistent data to eluci-
date the causal factors of the trend presented by
this population. It does not seem to reflect a de-
crease in the prevalence of anemia in males, but
it only increased the importance of other causes
related to lifestyle for the inability to donate blood.
It is noteworthy that although the nutri-
tional status was not evaluated, it is understood
that anemia in the last thirty years in Brazil is the
co-linear problem together with obesity and the
referred main deficiency. Overweight / obesity and
anemia may be associated with changes in food
intake as a substrate of the food and nutritional
transition in Brazil.
The priority of the International Organiza-
tions Agenda is the decrease of anemia in all
groups of risk.22 Specifically for women in repro-
ductive age, there is a target for reducing by one
third the prevalence of anemia. Accordingly, the
temporal trend of rise of anemia as a cause of
clinical disability coincides with the prevalence of
anemia in the female population in Brazil.
The current dietary pattern is associated
with increased incidence of non-communicable
chronic diseases like diabetes, hypertension, car-
diovascular disease, obesity and some types of
cancer. On the other hand, diseases that result
from caloric and micro nutritional eating habits,
such as malnutrition, deficiency of vitamin A,
anemia, have not been eradicated.23
Results showed a great number of volun-
tary donors, but unable to donate, with negative
effect in the cases of anemia in future donors and
it make them temporarily unable.
Probably, this study has been the only one
that has been held in the public service of
hemotherapy in Maranhão, that evaluated the
causes of clinical inability for blood donation. The
implementation of a consistent and routine sys-
tem for verification could help the diagnosis in real
time and to assess the donor’s profile.
Thus, strategies to recruit blood donors
need to consider that clinical disability exacer-
bates the problem of few donors. The establish-
ment and enhancement of partnerships between
the Hemocenter and the Municipal Health Depart-
ment, the University and the community is essen-
tial to conduct joint activities. Campaigns directed
to potential donors and for example, through the
Family Health Strategy would be important tools
to raise awareness and inform people about the
work developed by the Hemocenter, about the
importance of blood donation, but also to pre-
vent clinical obstacles for voluntary donations, as
anemia.
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The women’s group showed more disabil-
ity due to anemia; therefore, public policies could
be useful not only to decrease the prevalence of
anemia, but the number of temporary clinical un-
able candidates, as well.
CONCLUSION
Anemia has been responsible for consider-
able clinical disability rates among candidates for
blood donation in the state of Maranhão, in all
these years of evaluations; it is the second most
frequent cause of disability, especially in women,
alike the first one.
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